이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

AddLife 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Fredrik Dalborg

최고 경영자

SEK 6.0m

총 보상

CEO 급여 비율	31.6%
CEO 임기	2yrs
CEO 소유권	0.02%
경영진 평균 재임 기간	less than a year
이사회 평균 재임 기간	8.3yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Fredrik Dalborg 의 보수는 AddLife 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2023	n/a	n/a	SEK 292m
Jun 30 2023	n/a	n/a	SEK 387m
Mar 31 2023	n/a	n/a	SEK 429m
Dec 31 2022	SEK 6m	SEK 2m	SEK 480m

보상 대 시장: Fredrik 의 총 보상 ($USD 591.46K ) UK 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 2.38M ).

보상과 수익: Fredrik 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Fredrik Dalborg (51 yo)

2yrs

테뉴어

SEK 5,991,000

보상

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

리더십 팀

이름	위치	테뉴어	보상	소유권
Fredrik Dalborg	President & CEO	2yrs	SEK 5.99m	0.018% SEK 2.3m
Christina Rubenhag	Chief Financial Officer	2yrs	데이터 없음	0.0029% SEK 382.6k
Peter Simonsbacka	Chief Commercial Officer	less than a year	데이터 없음	0.060% SEK 8.0m
Christian Karlsson	Head of Business Development	3yrs	데이터 없음	데이터 없음
Per Wahlstedt	Head of Business Control	2yrs	데이터 없음	데이터 없음
Timmy Rosendal	Head of Sustainability	less than a year	데이터 없음	데이터 없음
Ioana Dragan	Head of Financial Control	less than a year	데이터 없음	데이터 없음
Jamilah Wass	Group Financial Controller	no data	데이터 없음	데이터 없음
Nichlas Essner	Group Business Controller	less than a year	데이터 없음	데이터 없음
Malin Lindh	Group Business Controller	less than a year	데이터 없음	데이터 없음

0.8yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: ALIFBS 의 관리팀은 경험 (평균 재직 기간 0.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Birgit Norinder	Independent Director	8.3yrs	SEK 350.00k	0.010% SEK 1.4m
Eva Elmstedt	Independent Director	2.7yrs	SEK 350.00k	0.0025% SEK 327.9k
Johan Sjo	Independent Chairman	8.8yrs	SEK 700.00k	0.14% SEK 18.1m
Håkan Roos	Independent Director	8.5yrs	SEK 350.00k	4.5% SEK 600.1m
Eva Nilsagard	Independent Director	8.1yrs	SEK 430.00k	0.0046% SEK 609.2k
Stefan Hedelius	Independent Director	8.3yrs	SEK 350.00k	0.024% SEK 3.2m

8.3yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: ALIFBS 의 이사회는 경험(평균 재직 기간 8.3 년)으로 간주됩니다.

AddLife 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought kr12m worth of stock

President & CEO recently bought kr129k worth of stock

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

President & CEO recently bought kr285k worth of stock

Recent updates

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

AddLife AB (publ), Annual General Meeting, May 08, 2024

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Independent Director recently bought kr12m worth of stock

Investor sentiment improves as stock rises 37%

President & CEO recently bought kr129k worth of stock

Addlife AB (Publ) Declares Dividend

Upcoming dividend of kr1.20 per share at 1.0% yield

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

President & CEO recently bought kr285k worth of stock

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Second quarter 2022 earnings released

Now 23% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold kr8.5m worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought kr5.8m worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold kr32m worth of stock

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Independent Chairman recently sold kr11m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr106k worth of stock

Independent Chairman recently sold kr7.0m worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr14m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

AddLife AB (Publ) Provides Earnings Guidance for 2021

New 90-day high: kr175

Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019)

New 90-day high: kr169

AddLife AB (publ) to Report Fiscal Year 2021 Results on Feb 03, 2022

New 90-day high: kr150

Insider recently bought kr692k worth of stock

AddLife AB (publ) (OM:ALIF B) completed the acquisition of the advanced surgery business of SIAD Healthcare S.p.A.

AddLife AB (publ) to Report Nine Months, 2021 Results on Oct 22, 2021

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Zafe Care Systems Ab.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Ropox A/S.

CEO 보상 분석

CEO

테뉴어